Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Baricitinib works better for alopecia areata in patients not previously treated with tofacitinib.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Oral JAK inhibitors are safe for alopecia areata, but baricitinib may cause more acne and infections.

Baricitinib can help improve hair loss and skin color issues in people with Down syndrome.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Baricitinib successfully treated myasthenia gravis and alopecia in a patient.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Upadacitinib may effectively treat resistant lichen planopilaris.

CI-1033 causes skin lesions in rats, similar to humans, due to EGF receptor inhibition.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Tislelizumab can cause cutaneous lupus erythematosus.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

Oral JAK inhibitors show promise for treating alopecia areata but have challenges like relapse and side effects.

Combination therapy, including JAK inhibitors, effectively regrows hair and reduces severity in Black children with stubborn Alopecia Areata.

Baricitinib may cause low blood sugar in some patients, so careful monitoring is needed.

Digital health technology improves health and medication adherence in kidney transplant patients.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

Janus kinase inhibitors are effective and safe for treating Alopecia Areata.

JAK-inhibitors are effective for treating psoriasis and show promise for other skin diseases.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.